403 related articles for article (PubMed ID: 28089346)
1. Detection of unusual very-long-chain fatty acid and ether lipid derivatives in the fibroblasts and plasma of patients with peroxisomal diseases using liquid chromatography-mass spectrometry.
Takashima S; Toyoshi K; Itoh T; Kajiwara N; Honda A; Ohba A; Takemoto S; Yoshida S; Shimozawa N
Mol Genet Metab; 2017 Mar; 120(3):255-268. PubMed ID: 28089346
[TBL] [Abstract][Full Text] [Related]
2. Very-long-chain polyunsaturated fatty acids accumulate in phosphatidylcholine of fibroblasts from patients with Zellweger syndrome and acyl-CoA oxidase1 deficiency.
Abe Y; Honsho M; Nakanishi H; Taguchi R; Fujiki Y
Biochim Biophys Acta; 2014 Apr; 1841(4):610-9. PubMed ID: 24418004
[TBL] [Abstract][Full Text] [Related]
3. Quantification of Very-Long-Chain and Branched-Chain Fatty Acids in Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
De Biase I; Pasquali M
Methods Mol Biol; 2022; 2546():509-521. PubMed ID: 36127618
[TBL] [Abstract][Full Text] [Related]
4. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders.
Takemoto Y; Suzuki Y; Horibe R; Shimozawa N; Wanders RJ; Kondo N
Brain Dev; 2003 Oct; 25(7):481-7. PubMed ID: 13129591
[TBL] [Abstract][Full Text] [Related]
5. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
6. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
[TBL] [Abstract][Full Text] [Related]
7. Measurement of plasma pristanic, phytanic and very long chain fatty acids by liquid chromatography-electrospray tandem mass spectrometry for the diagnosis of peroxisomal disorders.
Johnson DW; Trinh MU; Oe T
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(1):159-62. PubMed ID: 14630371
[TBL] [Abstract][Full Text] [Related]
8. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata.
Schutgens RB; Bouman IW; Nijenhuis AA; Wanders RJ; Frumau ME
Clin Chem; 1993 Aug; 39(8):1632-7. PubMed ID: 8353949
[TBL] [Abstract][Full Text] [Related]
9. A new multiplex method for the diagnosis of peroxisomal disorders allowing simultaneous determination of plasma very-long-chain fatty acids, phytanic, pristanic, docosahexaenoic and bile acids by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.
Semeraro M; Rizzo C; Boenzi S; Cappa M; Bertini E; Antonetti G; Dionisi-Vici C
Clin Chim Acta; 2016 Jul; 458():159-64. PubMed ID: 27189059
[TBL] [Abstract][Full Text] [Related]
10. Very-Long-Chain Fatty Acids Quantification by Gas-Chromatography Mass Spectrometry.
Scott AI
Methods Mol Biol; 2022; 2546():501-508. PubMed ID: 36127617
[TBL] [Abstract][Full Text] [Related]
11. Photosensitized killing of cultured fibroblasts from patients with peroxisomal disorders due to pyrene fatty acid-mediated ultraviolet damage.
Hoefler G; Paschke E; Hoefler S; Moser AB; Moser HW
J Clin Invest; 1991 Dec; 88(6):1873-9. PubMed ID: 1752949
[TBL] [Abstract][Full Text] [Related]
12. Molecular species of phospholipids with very long chain fatty acids in skin fibroblasts of Zellweger syndrome.
Hama K; Nagai T; Nishizawa C; Ikeda K; Morita M; Satoh N; Nakanishi H; Imanaka T; Shimozawa N; Taguchi R; Inoue K; Yokoyama K
Lipids; 2013 Dec; 48(12):1253-67. PubMed ID: 24122089
[TBL] [Abstract][Full Text] [Related]
13. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
Van Veldhoven PP; Huang S; Eyssen HJ; Mannaerts GP
J Inherit Metab Dis; 1993; 16(2):381-91. PubMed ID: 7692128
[TBL] [Abstract][Full Text] [Related]
14. Localization of nervonic acid beta-oxidation in human and rodent peroxisomes: impaired oxidation in Zellweger syndrome and X-linked adrenoleukodystrophy.
Sandhir R; Khan M; Chahal A; Singh I
J Lipid Res; 1998 Nov; 39(11):2161-71. PubMed ID: 9799802
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
Street JM; Singh H; Poulos A
Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
[TBL] [Abstract][Full Text] [Related]
16. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.
Wanders RJ; van Roermund CW; van Wijland MJ; Heikoop J; Schutgens RB; Schram AW; Tager JM; van den Bosch H; Poll-Thé BT; Saudubray JM
Clin Chim Acta; 1987 Jul; 166(2-3):255-63. PubMed ID: 2441904
[TBL] [Abstract][Full Text] [Related]
17. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
Molzer B; Stöckler S; Bernheimer H
Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
[TBL] [Abstract][Full Text] [Related]
18. A novel method for determining peroxisomal fatty acid β-oxidation.
Morita M; Matsumoto S; Okazaki A; Tomita K; Watanabe S; Kawaguchi K; Minato D; Matsuya Y; Shimozawa N; Imanaka T
J Inherit Metab Dis; 2016 Sep; 39(5):725-731. PubMed ID: 27324171
[TBL] [Abstract][Full Text] [Related]
19. Multivariate analysis and model building for classifying patients in the peroxisomal disorders X-linked adrenoleukodystrophy and Zellweger syndrome in Chinese pediatric patients.
Zhu Z; Genchev GZ; Wang Y; Ji W; Zhang X; Lu H; Sriswasdi S; Tian G
Orphanet J Rare Dis; 2023 May; 18(1):102. PubMed ID: 37189159
[TBL] [Abstract][Full Text] [Related]
20. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
